{
    "title": "Brain Tumor Radiogenomic Classification. (arXiv:2401.09471v1 [eess.IV])",
    "abstract": "The RSNA-MICCAI brain tumor radiogenomic classification challenge aimed to predict MGMT biomarker status in glioblastoma through binary classification on Multi parameter mpMRI scans: T1w, T1wCE, T2w and FLAIR. The dataset is splitted into three main cohorts: training set, validation set which were used during training, and the testing were only used during final evaluation. Images were either in a DICOM format or in Png format. different architectures were used to investigate the problem including the 3D version of Vision Transformer (ViT3D), ResNet50, Xception and EfficientNet-B3. AUC was used as the main evaluation metric and the results showed an advantage for both the ViT3D and the Xception models achieving 0.6015 and 0.61745 respectively on the testing set. compared to other results, our results proved to be valid given the complexity of the task. further improvements can be made through exploring different strategies, different architectures and more diverse datasets.",
    "link": "http://arxiv.org/abs/2401.09471",
    "context": "Title: Brain Tumor Radiogenomic Classification. (arXiv:2401.09471v1 [eess.IV])\nAbstract: The RSNA-MICCAI brain tumor radiogenomic classification challenge aimed to predict MGMT biomarker status in glioblastoma through binary classification on Multi parameter mpMRI scans: T1w, T1wCE, T2w and FLAIR. The dataset is splitted into three main cohorts: training set, validation set which were used during training, and the testing were only used during final evaluation. Images were either in a DICOM format or in Png format. different architectures were used to investigate the problem including the 3D version of Vision Transformer (ViT3D), ResNet50, Xception and EfficientNet-B3. AUC was used as the main evaluation metric and the results showed an advantage for both the ViT3D and the Xception models achieving 0.6015 and 0.61745 respectively on the testing set. compared to other results, our results proved to be valid given the complexity of the task. further improvements can be made through exploring different strategies, different architectures and more diverse datasets.",
    "path": "papers/24/01/2401.09471.json",
    "total_tokens": 857,
    "translated_title": "脑肿瘤放射基因分类",
    "translated_abstract": "RSNA-MICCAI脑肿瘤放射基因分类挑战旨在通过对多参数mpMRI扫描（T1w，T1wCE，T2w和FLAIR）进行二分类来预测胶质母细胞瘤中的MGMT生物标志物状态。数据集分为训练集、验证集和测试集。使用了不同的架构来研究该问题，包括3D版本的Vision Transformer（ViT3D）、ResNet50、Xception和EfficientNet-B3。AUC被用作主要的评估指标，结果显示ViT3D和Xception模型在测试集上分别达到了0.6015和0.61745的优势。与其他结果相比，我们的结果在任务的复杂性下证明是有效的。通过探索不同的策略、不同的架构和更多样化的数据集可以进一步改进。",
    "tldr": "本研究通过分析多参数mpMRI扫描来预测胶质母细胞瘤中的MGMT生物标志物状态，结果表明ViT3D和Xception模型具有优势，可作为有效的分类工具进行使用。",
    "en_tdlr": "This study predicts the MGMT biomarker status in glioblastoma using multi-parameter mpMRI scans, and the results show that the ViT3D and Xception models have an advantage and can be used as effective classification tools."
}